RT Journal Article
SR Electronic
T1 596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A678
OP A678
DO 10.1136/jitc-2023-SITC2023.0596
VO 11
IS Suppl 1
A1 Davar, Diwakar
A1 Eroglu, Zeynep
A1 Milhem, Mohammed
A1 Becerra, Carlos
A1 Gutierrez, Martin
A1 Ribas, Antoni
A1 Pace, Brian Di
A1 Wang, Tianli
A1 Zhang, Hailei
A1 Ghosh, Srimoyee
A1 Srivats, Shyam
A1 Dhar, Arindam
A1 Borgovan, Theo
A1 Waszak, Angela
A1 LoRusso, Patricia
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A678.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.